Peptide therapy TikTok claims: what the science actually supports

What did @loganshippy actually say?

The video is not really about peptides. It is about recruiting people into a sales network. @loganshippy flashes what appear to be daily sales figures totaling over $21,000 and invites followers to "shoot me a DM" to learn how to sell peptides and make money. The peptide health angle is a backdrop. The pitch is a business opportunity.

To be direct: this video is a recruitment post for what appears to be a multi-level or network marketing structure tied to peptide distribution. The phrase "help medical practices and also help my friends and followers" is doing a lot of work here, blurring the line between clinical supply and direct-to-consumer social media sales in a way that should raise immediate questions.

Does the science back this up?

There is no science to evaluate here because no specific health claims were made. That is itself worth noting. Peptides like BPC-157, TB-500, and CJC-1295 have early-stage research behind them, but none are FDA-approved drugs for human use in the United States. Selling them is a regulatory minefield, not a lifestyle brand.

BPC-157 has shown tissue repair effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but zero completed Phase III human trials exist. TB-500, a synthetic fragment of thymosin beta-4, has animal data on wound healing but no approved human formulation. CJC-1295 and ipamorelin are growth hormone secretagogues studied in small trials (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism) but not approved as consumer products. "Research chemicals" is the honest label. Selling them as wellness products is not the same thing.

What did they get wrong (or right)?

What they got right: peptides are a real and growing area of clinical interest, and compounding pharmacies do legitimately supply some of them to licensed providers. That part of the ecosystem exists.

What they got wrong is significant. Presenting peptide sales as an income opportunity for "friends and followers on social media" misrepresents how these substances can legally change hands. The FDA classifies most of these peptides as unapproved drugs. Selling unapproved drugs without a license is a federal violation. The FDA issued a guidance update in 2023 removing several peptides, including BPC-157 and TB-500, from the list of bulk substances that compounding pharmacies can use, tightening the legal picture further. Showing revenue screenshots and inviting random DMs to join a sales structure is not the same as operating within a licensed distribution framework.

What should you actually know?

If you are considering buying peptides from someone you found on TikTok, or joining their sales network, you should understand what you are actually looking at. Most peptides circulating in the wellness space are either sold as "not for human use" research chemicals or sourced through compounding pharmacies that require a valid prescription from a licensed provider.

The FDA's 2023 Interim Policy on Compounding removed BPC-157 and TB-500 from eligible bulk drug substances, meaning compounding pharmacies can no longer legally compound them for patient use in most circumstances. Purchasing from unregulated sources carries real risks including unknown purity, contamination, and incorrect dosing, none of which show up in a sales screenshot.

Network marketing structures built around regulated or semi-regulated substances also warrant serious scrutiny. If someone's primary pitch is the income opportunity rather than the clinical protocol, that is a signal worth paying attention to.